Cargando…
Healthcare Service Use Patterns Among Patients with Acid Sphingomyelinase Deficiency Type B: A Retrospective US Claims Analysis
INTRODUCTION: Acid sphingomyelinase deficiency (ASMD) is a rare lysosomal storage disease. Patients with ASMD type B experience multiple morbidities, potentially leading to early mortality. Before the 2022 approval of olipudase alfa for non-neuronopathic ASMD manifestations, only symptom management...
Autores principales: | Pulikottil-Jacob, Ruth, Ganz, Michael L., Fournier, Marie, Petruski-Ivleva, Natalia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129952/ https://www.ncbi.nlm.nih.gov/pubmed/36897522 http://dx.doi.org/10.1007/s12325-023-02453-w |
Ejemplares similares
-
Impact and burden of acid sphingomyelinase deficiency from a patient and caregiver perspective
por: Pokrzywinski, Robin, et al.
Publicado: (2021) -
Impact of Potential Symptoms and Risks Associated with Acid Sphingomyelinase Deficiency on Patients and Caregivers: A Best-Worst Scaling Study
por: Mansfield, Carol, et al.
Publicado: (2023) -
Chronic kidney disease progression among patients with type 2 diabetes identified in US administrative claims: a population cohort study
por: Kovesdy, Csaba P, et al.
Publicado: (2020) -
Annual health care resource utilization and cost among type 2 diabetes patients with newly recognized chronic kidney disease within a large U.S. administrative claims database
por: Folkerts, Kerstin, et al.
Publicado: (2020) -
Chronic opioid use and complication risks in women with endometriosis: A cohort study in US administrative claims
por: Chiuve, Stephanie E., et al.
Publicado: (2021)